Evidence map›Paper›PMID 24508507›Full record

ReviewCell metabolism2014

Peroxisomes: a nexus for lipid metabolism and cellular signaling.

Irfan J Lodhi, Clay F Semenkovich

Open access · bronzeAbstract readReview
In one paragraph

Review in Cell metabolism, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 325 papers.

0numbers the graph read from it
0cells of the map it votes in
325citing papers in PubMed
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

325 citing papers in PubMed, 587 citations in OpenAlex.

  1. Article
  2. Article
  3. More than the 'master regulator of cytosolic proteostasis': new roles for HSF1 in promoting tissue health.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2026
    Review
  4. Targeting the HPGDS-PGDSignal transduction and targeted therapy · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Polyunsaturated fatty acid metabolism in the retinal pigment epithelium and its association with outer retinal disease.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Review
  19. Anti-Obesity Effects ofInternational journal of molecular sciences · 2026
    Article
  20. Review

265 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Irfan J LodhiDivision of Endocrinology, Metabolism and Lipid Research; Department of Medicine, Washington University, St. Louis, MO 63110, USA. Electronic address: ilodhi@dom.wustl.edu.
Clay F SemenkovichDivision of Endocrinology, Metabolism and Lipid Research; Department of Medicine, Washington University, St. Louis, MO 63110, USA; Department of Cell Biology and Physiology, Washington University, St. Louis, MO 63110, USA. Electronic address: csemenko@wustl.edu.
Washington University in St. Louis · US

Funding

Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Brian N Finck · 1999 to 2026
$30.2M
WU P&FP30DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI David W Piston · 2013 to 2026
$27.1M
TRANSGENICS COREP60DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI SCHAFFER, JEAN E. · 1986 to 2012
$25.2M
DIABETES &RELATED METABOLIC DISEASEST32DK007120 · NIDDK · WASHINGTON UNIVERSITY · PI MARCO COLONNA, Maria Sara Remedi · 1986 to 2026
$15.7M
DE NOVO LIPOGENESIS AND METABOLIC DISEASER01DK076729 · NIDDK · WASHINGTON UNIVERSITY · PI SEMENKOVICH, CLAY F. · 2007 to 2015
$2.5M
OBESITY, ADIPOGENESIS, AND LIPID LIGANDSR01DK088083 · NIDDK · WASHINGTON UNIVERSITY · PI SEMENKOVICH, CLAY F. · 2010 to 2013
$1.3M
LIPOGENIC PATHWAYS IN ADIPOSE TISSUE DEVELOPMENT AND METABOLISMR00DK094874 · NIDDK · WASHINGTON UNIVERSITY · PI LODHI, IRFAN J · 2014 to 2016
$747k
LIPOGENIC PATHWAYS IN ADIPOSE TISSUE DEVELOPMENT AND METABOLISMK99DK094874 · NIDDK · WASHINGTON UNIVERSITY · PI LODHI, IRFAN J · 2013 to 2013
$90k
NIDDK NIH HHS DK076729NIDDK NIH HHS DK088083NIDDK NIH HHS DK20579NIDDK NIH HHS DK56341NIDDK NIH HHS K99 DK094874NIDDK NIH HHS P30 DK020579NIDDK NIH HHS P30 DK056341NIDDK NIH HHS P60 DK020579NIDDK NIH HHS R00 DK094874NIDDK NIH HHS R01 DK076729NIDDK NIH HHS R01 DK088083NIDDK NIH HHS T32 DK007120
6 · The paper itself

Abstract

Peroxisomes are often dismissed as the cellular hoi polloi, relegated to cleaning up reactive oxygen chemical debris discarded by other organelles. However, their functions extend far beyond hydrogen peroxide metabolism. Peroxisomes are intimately associated with lipid droplets and mitochondria, and their ability to carry out fatty acid oxidation and lipid synthesis, especially the production of ether lipids, may be critical for generating cellular signals required for normal physiology. Here, we review the biology of peroxisomes and their potential relevance to human disorders including cancer, obesity-related diabetes, and degenerative neurologic disease.

Indexed as

AdipocytesFatty AcidsHumansLipid MetabolismMitochondriaPeroxisomal DisordersPeroxisomesPhospholipid EthersPPAR gammaSignal TransductionFatty AcidsPhospholipid EthersPPAR gamma

Identifiers

PMID24508507
PMCPMC3951609
OpenAlexW2061013234

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.